European Companies Search Engine

Quick Search Power Search
Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Vita 34 AG, Leipzig, Germany

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

Vita 34 AG
VITA 34 International AG

Register

Ut
District Court of Leipzig HRB 20339
Stockp
VTIAF
Lei
529900OEWA4GSZEZ4P40

Address

Deutscher Platz 5 a, 04103 Leipzig, Germany

Corporate purpose

The collection, storage and distribution of cells, tissues, blood and blood components for the purpose of medical applications; the manufacture, storage and distribution of products based on cells, tissues, blood and blood components for the purpose of medical applications, in particular the production and manufacture of viral vectors as well as CAR-T cells or comparable products; research and development in the abovementioned areas; the development, manufacture and distribution of medical …

Financials

History

Legal Representatives

Marketing & Tech

Merger & Acquisition & Control

Network

Loading network

JOBS AT NORTH DATA

  • #1 Account Manager
  • Investigator in Residence
  • Modern Java Developer

Publications

5 Sept 2023 also 18/10/2022
Shareholder: Shareholder Value Beteiligungen AG
30 Aug 2023
Korrektur der HV-Einladung
24 Aug 2023
Annual report
17 Aug 2023
Ordentliche Hauptversammlung
24 May 2023
Annual report
19 May 2023
Consolidated Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022 · Earnings statement for 31/12/2022 · Shareholdings (42 companies)
16 May 2023
Consolidated Annual report for the year ending 31/12/2022
10 May 2023
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022 · Earnings statement for 31/12/2022
21 Apr 2023
Annual report
21 Apr 2023
Consolidated Annual report for the year ending 31/12/2022
31 Dec 2022
Balance sheet for 31/12/2022 · Earnings statement for 31/12/2022
10 Oct 2022
Officer: Andreas Schafhirt
12 Sept 2022
Member of the Executive Board: Dirk Plaga · No longer Member of the Executive Board: Andreas Schafhirt
4 Aug 2022
List of board members
15 Jul 2022
Company statute
6 Jul 2022
Mitteilung gemäß § 49 Abs. 1 Satz 1 Nr. 2 WpHG
24 Jun 2022 via Vita 34 Gesellschaft für Zelltransplantate mbH
Shareholding: Vita 34 Gesellschaft für Zelltransplantate mbH
13 Jun 2022
Officer: Georg Steinbacher
16 May 2022
Consolidated Annual report for the year ending 31/12/2021
28 Apr 2022
CEO: Jakub Julian Baran · Member of the Executive Board: Tomasz F. Baran · No longer CEO: Wolfgang J. Knirsch
7 Mar 2022
List of board members
4 Mar 2022 also 16/11/2021
Shareholder: Nationale-Nederlanden Powszechne Towarzystwo Emerytalne SA
18 Feb 2022
Annual report for the year ending 31/12/2020
1 Feb 2022
Wordmark: Stem Cell Unit Search
18 Jan 2022
Company statute · Corporate Purpose
31 Dec 2021
Balance sheet for 31/12/2021 · Earnings statement for 31/12/2021
16 Nov 2021 also 16/11/2021, 16/11/2021, 16/11/2021
Shareholder (1)
9 Nov 2021
Capital: €16M · Company statute
25 Aug 2021
Member of the Executive Board: Andreas Schafhirt · No longer Member of the Executive Board: Falk Neukirch
24 Aug 2021
Capital: €16.4M
18 Aug 2021
CEO: Wolfgang J. Knirsch
28 Jun 2021
Annual report
19 May 2021
Consolidated Annual report for the year ending 31/12/2020
18 May 2021
Annual report for the year ending 31/12/2020
18 May 2021
Consolidated Annual report for the year ending 31/12/2020
8 Feb 2021
No longer Officer (1)
31 Dec 2020
Balance sheet for 31/12/2020 · Earnings statement for 31/12/2020
4 Sept 2020
List of board members
22 Jul 2020
List of board members
14 Jul 2020
Annual report for the year ending 31/12/2019
31 Mar 2020
Consolidated Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019 · Shareholdings (10 companies)
30 Mar 2020
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019 · Shareholdings (9 companies)
20 Mar 2020
Corporate Purpose
31 Dec 2019
Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019
5 Dec 2019
The Annual General Meeting on 04.06.2019 approved the creation of Authorized Capital (Authorized Capital - 2019) and …
15 Jul 2019
Annual report for the year ending 31/12/2018
1 Jul 2019
Member of the Executive Board: Falk Neukirch
1 Jul 2019
List of board members
3 May 2019
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018 · Earnings statement for 31/12/2018 · Shareholdings (10 companies)
15 Apr 2019
Consolidated Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018 · Earnings statement for 31/12/2018 · Shareholdings (14 companies)
5 Apr 2019
List of board members
31 Dec 2018
Balance sheet for 31/12/2018 · Earnings statement for 31/12/2018
26 Oct 2018 via stellacure GmbH
Merger: stellacure GmbH
6 Sept 2018
Wordmark: ADIPOVITA
6 Sept 2018
Wordmark: VITAPUR
Year 2018 in Dm
6 wordmarks: ADIPOVITA, VITA 34, VITAMEINS&DEINS, VITAPLUSSPENDE, VITAPUR …
17 Aug 2018
Wordmark: VITA 34
15 Aug 2018
CEO: Wolfgang J. Knirsch
23 Jul 2018
Merger: stellacure GmbH
16 Jul 2018 via Vita 34 Suisse GmbH
Shareholding: Vita 34 Suisse GmbH
19 Jun 2018
Annual report for the year ending 31/12/2017
25 Apr 2018
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017 · Earnings statement for 31/12/2017 · Shareholdings (10 companies)
17 Apr 2018
Consolidated Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017 · Earnings statement for 31/12/2017 · Shareholdings (17 companies)
22 Mar 2018
No longer Member of the Executive Board: Alexander L. Starke
31 Dec 2017
Balance sheet for 31/12/2017 · Earnings statement for 31/12/2017
1 Dec 2017
Word figurative mark
10 Oct 2017
Member of the Executive Board: Falk Neukirch
11 Sept 2017
Company statute
8 Sept 2017
Officer (1)
8 Aug 2017
List of board members
31 Jul 2017
Capital: €4,145,959
20 Jul 2017
Annual report for the year ending 31/12/2016
16 Jun 2017
Capital: €3,329,149
15 Jun 2017
CEO: Wolfgang Knirsch · Member of the Executive Board: Alexander L. Starke · No longer Member of the Executive Board: André Gerth
15 Jun 2017
List of board members
30 May 2017 via Landesbank Baden-Württemberg, also 13/04/2017, 13/04/2017, 13/04/2017, 27/03/2017, 24/04/2014, 19/09/2013
Shareholder: Landesbank Baden-Württemberg
19 May 2017
Correction/addition to the entry under order number 33: By resolution of the Annual General Meeting, the Management …
16 May 2017
No longer Member of the Executive Board: Falk Neukirch
15 May 2017
Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016 · Earnings statement for 31/12/2016 · Shareholdings (8 companies)
28 Apr 2017
Consolidated Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016 · Earnings statement for 31/12/2016 · Shareholdings (10 companies)
4 Jan 2017
Patent: Method for the Treatment of Umbilical Cord Tissue, in Particular Associated with the Preservation of the Tissue
31 Dec 2016
Balance sheet for 31/12/2016 · Earnings statement for 31/12/2016
15 Sept 2016
Company statute
6 Sept 2016
Annual report for the year ending 31/12/2015
21 Jul 2016
Annual report for the year ending 31/12/2015
28 Jun 2016
Consolidated Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015 · Shareholdings (12 companies)
13 Jun 2016
Member of the Executive Board: Wolfgang Knirsch
13 Jun 2016
Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015 · Shareholdings (11 companies)
20 Jan 2016
No longer Officer (1)
31 Dec 2015
Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015
14 Oct 2015
Member of the Executive Board: Falk Neukirch · No longer Member of the Executive Board: Jörg Ulbrich
3 Sept 2015
Officer (1)
11 Aug 2015
Annual report for the year ending 31/12/2014
10 Aug 2015
Company statute
11 Jun 2015
Annual report for the year ending 31/12/2014
7 May 2015
Annual report for the year ending 31/12/2014 · Balance sheet for 31/12/2014 · Earnings statement for 31/12/2014 · Shareholdings (5 companies)
6 May 2015
Consolidated Annual report for the year ending 31/12/2014 · Balance sheet for 31/12/2014 · Earnings statement for 31/12/2014
31 Dec 2014
Balance sheet for 31/12/2014 · Earnings statement for 31/12/2014
17 Sept 2014
Capital: €3,026,500 · Company statute
22 Aug 2014
List of board members
1 Aug 2014
Public funding (€153,192): NanoSuppe - Verhalten von synthetischen Nanopartikeln im Wirkungspfad Abwasser - Klärschlamm - Pflanze am Beispiel TiO2, CeO2, MWCNT und Quantum dots
23 Jul 2014
Patent: Methods for the treatment of umbilical cord tissue, in particular in connection with the preservation of tissue
23 May 2014
Annual report for the year ending 31/12/2013 · Balance sheet for 31/12/2013 · Earnings statement for 31/12/2013 · Shareholdings (5 companies)
23 May 2014
Consolidated Annual report for the year ending 31/12/2013 · Balance sheet for 31/12/2013 · Earnings statement for 31/12/2013
1 May 2014
Public funding (€98,484): ERA-IB 4: NBCPBH - Produktion neuer bioaktiver Verbindungen durch Pflanzen und Bakterien mit Hilfe neuer und verbesserter Halogenasen, Teilprojekt C (Vita 34)
31 Dec 2013
Balance sheet for 31/12/2013 · Earnings statement for 31/12/2013
30 Oct 2013
Annual report for the year ending 31/12/2011
10 Oct 2013
No longer Officer (1)
10 Oct 2013
List of board members
15 Aug 2013
Company statute · Corporate Purpose
1 Aug 2013
Public funding (€118,515): INTECRAL: Integrierte Ökotechnologien und -dienstleistungen für eine nachhaltige ländliche Entwicklung in Rio de Janeiro - TP Renaturierung und Training
1 Aug 2013
Public funding (€186,358): Sicherung/Bewirtschaftung des Deponiestandortes Gò Cát in Ho Chi Minh City unter dem Aspekt der Optimierung von Klimaschutz und Landnutzung (SAFEUSE) - Teilprojekt 4 …
26 Jul 2013
Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012 · Earnings statement for 31/12/2012
26 Jul 2013
Consolidated Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012 · Earnings statement for 31/12/2012
3 Jun 2013
Merger: Bio Planta GmbH
26 Feb 2013
Annual report for the year ending 31/12/2010
10 Jan 2013
Name: Vita 34 AG · Company statute
8 Jan 2013
Member of the Executive Board: Jörg Ulbrich
31 Dec 2012
Balance sheet for 31/12/2012 · Earnings statement for 31/12/2012
6 Dec 2012 via Bio Planta GmbH
Merger: Bio Planta GmbH
6 Dec 2012
Merger: Bio Planta GmbH
11 Oct 2012
At the register court, the draft of a merger agreement between Bio Planta GmbH as transferring...
23 Aug 2012
Capital: €3,026,500
16 Aug 2012
List of board members
9 Aug 2012
No longer Member of the Executive Board (1)
7 Jun 2012
Member of the Executive Board: André Gerth
31 May 2012
Member of the Executive Board: Jörg Ulbrich
18 Apr 2012
Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011 · Earnings statement for 31/12/2011
18 Apr 2012
Consolidated Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011 · Earnings statement for 31/12/2011 · Shareholdings: Novel Pharma SL, Secuvita SL
31 Dec 2011
Balance sheet for 31/12/2011 · Earnings statement for 31/12/2011
8 Dec 2011
Annual report for the year ending 31/12/2009
1 Sept 2011
Officer (1)
18 Aug 2011 via Vita 34 AG, also 01/06/2011
Merger: Vita 34 AG
18 Aug 2011
Merger: Vita 34 AG · Address · Name: VITA 34 AG · Company statute · Corporate Purpose
3 Jun 2011
Wordmark: Vita 34 direkt
1 Jun 2011 as VITA 34 International AG
Merger: VITA 34 AG
16 May 2011 as VITA 34 International AG
Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010 · Earnings statement for 31/12/2010 · Shareholdings (4 companies)
13 May 2011 as VITA 34 International AG
Consolidated Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010 · Earnings statement for 31/12/2010 · Shareholdings: Novel Pharma SL, Secuvita SL, VITA 34 AG
31 Dec 2010
Balance sheet for 31/12/2010 · Earnings statement for 31/12/2010
1 Oct 2010
Public funding (€135,004): Entscheidungsunterstützungssystem für salzhaltige Wässer EUSSaWa, Teilprojekt 3
23 Sept 2010 as VITA 34 International AG
List of board members
22 Jul 2010 as VITA 34 International AG
Company statute
22 Mar 2010 as VITA 34 International AG
Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009 · Earnings statement for 31/12/2009 · Shareholdings: CorCell Inc., VITA 34 AG
22 Mar 2010 as VITA 34 International AG
Consolidated Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009 · Earnings statement for 31/12/2009
31 Dec 2009
Balance sheet for 31/12/2009 · Earnings statement for 31/12/2009
17 Dec 2009 as VITA 34 International AG
Member of the Executive Board: Jörg Ulbrich · No longer Officer: Jörg Ulbrich · No longer Member of the Executive Board (1)
2 Dec 2009
Patent: Medical Bag System for Cryo-Preservation
28 Sept 2009 as VITA 34 International AG
Consolidated Annual report for the year ending 31/12/2008 · Balance sheet for 31/12/2008 · Earnings statement for 31/12/2008
3 Sept 2009 as VITA 34 International AG
List of board members
31 Aug 2009 as VITA 34 International AG
Annual report for the year ending 31/12/2008 · Balance sheet for 31/12/2008 · Earnings statement for 31/12/2008 · Shareholdings: CorCell Inc., VITA 34 AG
27 Aug 2009 as VITA 34 International AG
List of board members
6 Aug 2009 as VITA 34 International AG
Company statute
31 Dec 2008
Balance sheet for 31/12/2008 · Earnings statement for 31/12/2008
11 Sept 2008 as VITA 34 International AG
Company statute
6 Mar 2008 as VITA 34 International AG
Consolidated Annual report for the year ending 31/12/2007 · Balance sheet for 31/12/2007 · Earnings statement for 31/12/2007
5 Mar 2008 as VITA 34 International AG
Annual report for the year ending 31/12/2006 · Balance sheet for 31/12/2006 · Earnings statement for 31/12/2006 · Shareholdings: CorCell Inc., VITA 34 AG
24 Jan 2008 as VITA 34 International AG
Annual report for the year ending 31/12/2006
1 Jan 2008
Public funding (€205,873): Bergbau und Umwelt Vietnam / Unterverbund Pflanzenbasierte Methoden zur nachhaltigen Haldenrekultivierung und Behandlung von Bergbauwässern TP: Konzeption zur praktischen …
31 Dec 2007
Balance sheet for 31/12/2007 · Earnings statement for 31/12/2007
29 Nov 2007 as VITA 34 International AG
Company statute
26 Sept 2007
Consolidated Annual report for the year ending 31/12/2006 · Balance sheet for 31/12/2006 · Earnings statement for 31/12/2006 · Shareholdings (134 companies)
11 Sept 2007 via Concord Effekten AG
Shareholder: Concord Effekten AG
13 Aug 2007 as VITA 34 International AG
Annual report for the year ending 31/12/2006 · Balance sheet for 31/12/2006 · Earnings statement for 31/12/2006 · Shareholdings: CorCell Inc., VITA 34 AG
20 Jun 2007 via Concord Investmentbank AG
Shareholder: Concord Effekten AG
29 Mar 2007 as VITA 34 International AG
Capital: €2,646,500
22 Mar 2007 as VITA 34 International AG
Die Hauptversammlung vom 10.01.2007 hat die Schaffung eines neuen Genehmigten Kapitals unter gleichzeitiger Aufhebung…
22 Feb 2007 as VITA 34 International AG
Company statute
13 Feb 2007 as VITA 34 International AG
Annual report for the year ending 31/12/2005
1 Jan 2007
Public funding (€178,280): Innovative Pflanzenerzeugung im Temporären Immersions System - Teilvorhaben 2
31 Dec 2006
Balance sheet for 31/12/2006 · Earnings statement for 31/12/2006
1 Jul 2006
Public funding (€132,721): Erschließung und Charakterisierung therapeutisch neuroprotektiver und anti-inflammatorischer Wirkstoffe aus Harpagophytum procumbens (Teufelskralle) -THERATEK-
16 Jun 2006
Word figurative mark
30 Mar 2006 as VITA 34 International AG
No longer Member of the Executive Board (1)
27 Oct 2005 as VITA 34 International AG
Capital: €2,046,500
7 Jul 2005 as VITA 34 International AG
Member of the Executive Board (1)
23 Dec 2004
Officer: Jörg Ulbrich · Company statute
3 Nov 2004
German Trade Register daily updates
25 Oct 2004
German Trade Register daily updates
30 Jun 2004
Capital: €1,726,500 · Company statute
28 Jun 2004
Capital: €1,726,500 · Company statute · Corporate Purpose
17 Jun 2004
Capital: €1,726,500
9 Feb 2004
No longer Member of the Executive Board: Jörg Ulbrich · Member of the Executive Board (2)
19 Jan 2004 as VITA 34 International AG
Reg­is­tra­tion · Member of the Executive Board: Jörg Ulbrich · Capital: €50,000 · Seat: Leipzig · Legal form: AG · Name: VITA 34 International AG · Corporate Purpose

Mentions

3 Jul 2023 via Polski Bank Komórek Macierzystych S.A.
Direct parent: Polski Bank Komórek Macierzystych S.A
3 Jul 2023 via Polski Bank Komórek Macierzystych S.A.
Ultimate parent: Polski Bank Komórek Macierzystych S.A
30 Jun 2023 via KRIO Intézet Sejt- és Szövetbank Zrt.
Direct parent: KRIO Intézet Sejt- és Szövetbank Zrt
30 Jun 2023 via KRIO Intézet Sejt- és Szövetbank Zrt.
Ultimate parent: KRIO Intézet Sejt- és Szövetbank Zrt
28 Oct 2022 via Secuvita SL
Ultimate parent: Secuvita SL

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "Vita 34 AG, Leipzig, Germany" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.
Close